Contraceptive
ANVISA discloses alert physicians after study pills associate the risk of thrombosis
ANVISA (National Health Surveillance Agency) calls for health professionals to notify the institution any serious adverse reactions in women taking contraceptives containing the hormone dross pine cone, even if the reactions are described in Bull.
The pills with the substance are known in the Brazilian market by brands Yazd and Jasmine check the real deal

Notifications must be made by the system Not visa, available on the ANVISA.
This closer monitoring is due to recent studies published in the British Medical Journal and on the website of the U.S. agency for medicines and foods, the FDA (Food and Drugs Administration).

Study released by the FDA on Wednesday suggests an increased risk formation of blood clots, venous thrombosis and pulmonary embolism. Two articles published in the British Medical Journal (BMJ) raised the same question.
's patients using contraceptive containing the hormone drospirenone should follow all recommendations of the doctor who accompanies them.

 It is important to communicate to the doctor immediately if they develop adverse reactions during use, even if the reactions appear on the labe check the real deal

Observation In
ANVISA inform healthcare professionals and patients who have not completed final opinion about the drugs, but still watching it.



Leave a Reply.